1. BMC Pediatr. 2015 Sep 21;15:132. doi: 10.1186/s12887-015-0451-3.

Could caregiver reporting adherence help detect virological failure in 
Cameroonian early treated HIV-infected infants?

Ateba Ndongo F(1), Warszawski J(2), Texier G(3), Penda I(4), Tetang Ndiang S(5), 
Ndongo JA(6), Guemkam G(7), Sofeu CL(8), Kfutwah A(9), Faye A(10), Msellati 
P(11), Tejiokem MC(12); ANRS-PEDIACAM study group.

Author information:
(1)Université Paris-Sud; Centre Mère et Enfant de la Fondation Chantal Biya, POB 
1936, Yaounde, Cameroon. atebfranc@gmail.com.
(2)Université Paris-Sud; Assistance Publique des Hôpitaux de Paris, CESP INSERM 
U1018, team 4 "HIV and STD"; Hôpital Bicêtre, 94276, Le Kremlin-Bicêtre, France. 
josiane.warszawski@inserm.fr.
(3)SESSTIM (UMR 912) Aix-Marseille Université, Marseille, France. 
gaetex1@gmail.com.
(4)Université Douala; Hôpital Laquintinie, POB 4035, Douala, Cameroon. 
idapenda@yahoo.fr.
(5)Centre Hospitalier d'Essos, POB 5777, Yaounde, Cameroon. 
ndiangsuzie@yahoo.fr.
(6)Centre Mère et Enfant de la Fondation Chantal Biya, POB 1936, Yaounde, 
Cameroon. jeanndongo@yahoo.fr.
(7)Centre Mère et Enfant de la Fondation Chantal Biya, POB 1936, Yaounde, 
Cameroon. guemgeorg@hotmail.com.
(8)Université Yaoundé I; Centre Pasteur du Cameroun, Service d'Epidémiologie et 
de Santé Publique, POB 1274, Yaounde, Cameroon. scl.ledoux@gmail.com.
(9)Centre Pasteur du Cameroun, Service de Virologie, POB 1274, Yaounde, 
Cameroon. kfutwah@pasteur-yaounde.org.
(10)Université Paris Diderot, Sorbonne Paris Cité; Assistance Publique des 
Hôpitaux de Paris, Pédiatrie Générale, Hôpital Robert Debré, Paris, France. 
albert.faye@rdb.aphp.fr.
(11)UMI 233, IRD, Université Montpellier, POB 64501, 34394, Montpellier, France. 
philippe.msellati@ird.fr.
(12)Centre Pasteur du Cameroun, Service d'Epidémiologie et de Santé Publique, 
POB 1274, Yaounde, Cameroon. temacy@yahoo.fr.

BACKGROUND: Viral load is still the marker of choice for monitoring adherence to 
combined antiretroviral therapy (cART) and confirming the success of HIV 
treatment. Unfortunately it is difficult to access in many resource-poor 
settings. We aimed to measure the performance of caregiver reporting adherence 
for detecting virological failure in routine practice during the first 2 years 
after cART initiation in infants.
METHODS: PEDIACAM is an ongoing prospective cohort study including HIV1-infected 
infants diagnosed before 7 months of age between November 2007 and October 2011 
in Cameroon. Adherence was assessed using a questionnaire administered every 3 
months from cART initiation; the HIV-RNA viral load was determined at the same 
visits. Virological failure was defined as having a viral load ≥ 1000 cp/mL at 3 
and 12 months after cART initiation or having a viral load ≥ 400 cp/mL at 24 
months after cART initiation. The performance of each current missed and 
cumulative missed dose defined according to adherence as reported by caregiver 
was assessed using the viral load as the gold standard.
RESULTS: cART was initiated at a median age of 4 months (IQR: 3-6) in the 167 
infants included. The cumulative missed dose showed the best overall performance 
for detecting virological failure after 12 months of cART (AUC test, p = 0.005, 
LR + =4.4 and LR- = 0.4). Whatever the adherence reporting criterion, the 
negative predictive value was high (NPV ≥ 75%) 12 and 24 months after cART 
initiation, whereas the positive predictive value was low (PPV ≤ 50%).
CONCLUSIONS: The adherence questionnaire administered by the health care 
provider to the infants' caregivers is not reliable for detecting virological 
failure in routine practice: its positive predictive value is low. However, the 
cumulative missed dose measurement may be a reliable predictor of virological 
success, particularly after 12 months of cART, given its high negative 
predictive value.

DOI: 10.1186/s12887-015-0451-3
PMCID: PMC4578260
PMID: 26391474 [Indexed for MEDLINE]